BlackRock’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$169M Sell
12,053,345
-1,781,611
-13% -$24.9M ﹤0.01% 1712
2025
Q1
$188M Sell
13,834,956
-85,289
-0.6% -$1.16M ﹤0.01% 1623
2024
Q4
$284M Buy
13,920,245
+131,728
+1% +$2.68M 0.01% 1440
2024
Q3
$402M Buy
13,788,517
+613,955
+5% +$17.9M 0.01% 1221
2024
Q2
$306M Buy
13,174,562
+974,706
+8% +$22.6M 0.01% 1333
2024
Q1
$250M Buy
12,199,856
+656,410
+6% +$13.5M 0.01% 1487
2023
Q4
$248M Buy
11,543,446
+658,150
+6% +$14.1M 0.01% 1497
2023
Q3
$225M Buy
10,885,296
+779,021
+8% +$16.1M 0.01% 1447
2023
Q2
$298M Buy
10,106,275
+631,878
+7% +$18.6M 0.01% 1294
2023
Q1
$218M Buy
9,474,397
+152,383
+2% +$3.51M 0.01% 1472
2022
Q4
$259M Buy
9,322,014
+723,802
+8% +$20.1M 0.01% 1336
2022
Q3
$264M Sell
8,598,212
-186,420
-2% -$5.72M 0.01% 1260
2022
Q2
$259M Buy
8,784,632
+598,892
+7% +$17.6M 0.01% 1331
2022
Q1
$263M Buy
8,185,740
+74,918
+0.9% +$2.41M 0.01% 1455
2021
Q4
$362M Buy
8,110,822
+549,985
+7% +$24.5M 0.01% 1273
2021
Q3
$381M Buy
7,560,837
+524,796
+7% +$26.5M 0.01% 1201
2021
Q2
$552M Buy
7,036,041
+471,589
+7% +$37M 0.02% 940
2021
Q1
$375M Buy
6,564,452
+188,374
+3% +$10.8M 0.01% 1263
2020
Q4
$534M Buy
6,376,078
+290,761
+5% +$24.4M 0.02% 843
2020
Q3
$218M Sell
6,085,317
-172,265
-3% -$6.17M 0.01% 1310
2020
Q2
$151M Buy
6,257,582
+991,226
+19% +$24M 0.01% 1550
2020
Q1
$92.2M Buy
5,266,356
+18,778
+0.4% +$329K ﹤0.01% 1688
2019
Q4
$91.4M Buy
5,247,578
+669
+0% +$11.7K ﹤0.01% 2014
2019
Q3
$80.4M Buy
5,246,909
+92,812
+2% +$1.42M ﹤0.01% 2011
2019
Q2
$107M Buy
5,154,097
+604,766
+13% +$12.6M ﹤0.01% 1854
2019
Q1
$106M Sell
4,549,331
-23,364
-0.5% -$543K ﹤0.01% 1833
2018
Q4
$94.5M Buy
4,572,695
+1,265,645
+38% +$26.1M ﹤0.01% 1835
2018
Q3
$71.9M Buy
3,307,050
+2,185,692
+195% +$47.5M ﹤0.01% 2173
2018
Q2
$17.1M Buy
1,121,358
+67,420
+6% +$1.03M ﹤0.01% 2926
2018
Q1
$20.8M Buy
+1,053,938
New +$20.8M ﹤0.01% 2739